Peginterferon alfa-2a plus ribavirin for treating chronic hepatitis C virus infection: Analysis of Mexican patients included in a multicenter international clinical trial
Treatment with polyethylene glycol-modified interferon alfa-2a (peginterferon) alone produces significantly higher sustained antiviral responses than treatment with interferon alfa-2a alone in patients with chronic hepatitis C virus (HCV) infection. We compared the efficacy and safety of peginterfer...
Autores principales: | , , , , , , , |
---|---|
Formato: | Artículo |
Lenguaje: | English |
Publicado: |
2003
|
Materias: | |
Acceso en línea: | http://eprints.uanl.mx/23487/1/23487.pdf |